Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Dec. 16, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 16, 2013

Alcobra, Alnylam, BioLineRx, Cubist, Gilead, La Jolla, NeoStem, PharmAthene, Recipharm, Shield

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II
Alcobra posts adult ADHD results . . . read more

Alnylam begins subcutaneous ATTR treatment trial . . . read more

Initial results in for BioLineRx AML trial . . . read more

La Jolla begins CKD trial . . . read more

NeoStem completes enrollment in CV trial . . . read more

Phase III
Cubist posts topline results from cIAI trial . . . read more

Filings
Gilead Complera one-tab HIV regimen approved for new patient group . . . read more

PharmAthene trial placed on clinical hold . . . read more

Recipharm unit files infectious app . . . read more

Shield cleared for CKD trial . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics